DNER and cancer: The most delighted thing is that a number of BET inhibitors such as RVX-208 (RVX00022), I-BET762 (GSK525762), FT-1101, CPI-0610, BAY1238097, INCB054329, TEN-010, GSK2820151, ZEN003694, BMS-986158, BI 894999, ABBV-075, GS-5829, PLX51107 and OTX015 (MK-8628) have been under clinical trials to investigate numerous cancer types or other diseases (Table 2).